Stay updated on PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.

Latest updates to the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page adds new user-guidance sections and reflects a recruitment status change, including No longer looking for participants, How to Read a Study Record, Common Questions, and How to Join a Study, and standardizes the Intervention/Treatment label. It also updates the page revision to v3.6.0 and removes the older Intervention / Treatment label and Revision: v3.5.5.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page revision updated from v3.5.4 to v3.5.5, indicating a new version of the ClinicalTrials.gov record.SummaryDifference0.1%

- Check38 days agoChange DetectedRevision: v3.5.4 is now displayed, replacing the previous v3.5.3. This is an administrative update to the page's revision metadata and does not modify study content or results.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s footer release version was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a change to the ClinicalTrials.gov site version rather than the underlying study record.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check95 days agoChange Detected- Revision: v3.5.0 added. - Revision: v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to PK and Safety of Omalizumab in Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PK and Safety of Omalizumab in Healthy Subjects Clinical Trial page.